Table 2.
Group number | Dosage regimen |
---|---|
Gp 1: Placebo (control) | Saline (2 ml/kg) intraperitoneally (i.p.) once then administered orally saline at dose of 5 ml/kg daily |
Gp 2:MERS infected (untreated) | Intranasally infected with 105 pfu/50 μl of virus |
Gp 3: Piperine suspension-treated GP | After infection an oral dose of 50 mg/kg (Selvendiran et al., 2006) once a day for 6 days |
Gp 4: Piperine bilosome-treated GP | After infection an oral dose of 50 mg/kg (Selvendiran et al., 2006) once a day for 6 days |